BROSSARD, Quebec - Diagnos Inc., a leader in early detection of critical health issues through AI technology, has successfully completed a non-brokered private placement on September 5, 2025. The private placement involved the issuance of 10 units (each valued at $10,000) for a total of $100,000 in gross proceeds. The company, listed as TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A, announced the initiation of the private placement on September 3, 2025.